Fagron NV (Belgium) Performance
| FAGR Stock | EUR 18.60 0.02 0.11% |
The firm shows a Beta (market volatility) of 0.34, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fagron NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fagron NV is expected to be smaller as well. At this point, Fagron NV has a negative expected return of -0.0407%. Please make sure to confirm Fagron NV's coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if Fagron NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Fagron NV has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Fagron NV is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 84.2 M | |
| Total Cashflows From Investing Activities | -31.9 M |
Fagron |
Fagron NV Relative Risk vs. Return Landscape
If you would invest 1,916 in Fagron NV on August 30, 2024 and sell it today you would lose (56.00) from holding Fagron NV or give up 2.92% of portfolio value over 90 days. Fagron NV is generating negative expected returns and assumes 1.0022% volatility on return distribution over the 90 days horizon. Simply put, 8% of stocks are less volatile than Fagron, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Fagron NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fagron NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Fagron NV, and traders can use it to determine the average amount a Fagron NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0406
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FAGR |
Estimated Market Risk
| 1.0 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fagron NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fagron NV by adding Fagron NV to a well-diversified portfolio.
Fagron NV Fundamentals Growth
Fagron Stock prices reflect investors' perceptions of the future prospects and financial health of Fagron NV, and Fagron NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fagron Stock performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0664 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 1.23 B | |||
| Shares Outstanding | 72.89 M | |||
| Price To Earning | 30.14 X | |||
| Price To Book | 2.48 X | |||
| Price To Sales | 1.47 X | |||
| Revenue | 573.81 M | |||
| EBITDA | 110.94 M | |||
| Cash And Equivalents | 394 K | |||
| Cash Per Share | 1.08 X | |||
| Total Debt | 321.27 M | |||
| Debt To Equity | 157.30 % | |||
| Book Value Per Share | 5.10 X | |||
| Cash Flow From Operations | 78.42 M | |||
| Earnings Per Share | 0.96 X | |||
| Total Asset | 800.42 M | |||
About Fagron NV Performance
Assessing Fagron NV's fundamental ratios provides investors with valuable insights into Fagron NV's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fagron NV is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Fagron NV, a pharmaceutical compounding company, provides personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. Fagron NV was founded in 1990 and is based in Nazareth, Belgium. Fagron NV operates under Healthcare Products classification in Belgium and is traded on Brussels Stock Exchange. It employs 2360 people.Things to note about Fagron NV performance evaluation
Checking the ongoing alerts about Fagron NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fagron NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fagron NV generated a negative expected return over the last 90 days | |
| Fagron NV has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 86.0% of the company shares are owned by institutional investors |
- Analyzing Fagron NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fagron NV's stock is overvalued or undervalued compared to its peers.
- Examining Fagron NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fagron NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fagron NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fagron NV's stock. These opinions can provide insight into Fagron NV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fagron Stock Analysis
When running Fagron NV's price analysis, check to measure Fagron NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fagron NV is operating at the current time. Most of Fagron NV's value examination focuses on studying past and present price action to predict the probability of Fagron NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fagron NV's price. Additionally, you may evaluate how the addition of Fagron NV to your portfolios can decrease your overall portfolio volatility.